The Democratic Republic of Congo confirmed Thursday a new Ebola outbreak in Ituri Province, with 80 deaths reported since the first suspected cases emerged in late April, according to the Africa Centres for Disease Control and Prevention.The World Health Organization has deployed rapid response teams to the remote northeastern region, approximately 30 kilometers from the Uganda border, where healthcare infrastructure remains severely limited and armed conflict complicates containment efforts."Laboratory tests have confirmed the presence of Ebola virus disease," said Dr. Jean Kaseya, director of Africa CDC, in a statement Thursday evening. "We are working closely with DRC health authorities to establish isolation facilities, initiate contact tracing, and deploy vaccines to healthcare workers and high-risk populations."The outbreak, Congo's 16th since the virus was first identified near the Ebola River in 1976, underscores the persistent public health challenges facing the vast Central African nation. Despite significant advances in Ebola treatment and prevention over the past decade—including the development of effective vaccines and therapeutics—the DRC continues to face periodic outbreaks due to its proximity to natural reservoir species and endemic weaknesses in its health system.To understand today's headlines, we must look at yesterday's decisions. The 2018-2020 Ebola epidemic in eastern Congo killed more than 2,200 people and strained the international response system. That outbreak, the second-deadliest in history after West Africa's 2014-2016 crisis, occurred in an active conflict zone where militia violence, community mistrust, and attacks on health workers repeatedly disrupted containment operations.Lessons from that experience have shaped the current response. The WHO and Africa CDC now maintain pre-positioned vaccine stockpiles and trained rapid response teams capable of deployment within 48 hours. Ring vaccination strategies—immunizing contacts of confirmed cases and their contacts—have proven highly effective when implemented quickly.However, Ituri Province presents familiar challenges. The region has experienced persistent armed conflict, with numerous militia groups competing for control of mineral-rich territories. Displaced populations live in makeshift camps with limited access to clean water, sanitation, or healthcare—conditions that facilitate disease transmission. said , WHO Regional Director for Africa, in remarks to journalists. Ebola virus disease causes severe hemorrhagic fever with fatality rates ranging from 25 to 90 percent, depending on the virus strain and access to treatment. Early symptoms include sudden fever, intense weakness, muscle pain, and headaches, which can progress to vomiting, diarrhea, rash, and both internal and external bleeding.The disease spreads through direct contact with blood, bodily fluids, or contaminated surfaces from infected individuals. Healthcare workers, family members caring for the sick, and traditional burial practices involving touching of deceased bodies have historically been high-risk factors for transmission.Congolese health authorities have established treatment centers in , the provincial capital, and are working to identify all individuals who may have had contact with confirmed cases. Mobile laboratories have been deployed to speed diagnostic testing, reducing the lag time that in previous outbreaks allowed undetected transmission chains to expand.The international community has pledged support, though the response has been complicated by competing health emergencies. The ongoing mpox outbreak in , continued COVID-19 surveillance, and measles epidemics in multiple countries have stretched WHO resources thin.Vaccine manufacturer Merck has confirmed it is coordinating with WHO to deploy doses of Ervebo, the licensed Ebola vaccine, though quantities may be limited depending on outbreak scale. The company noted that manufacturing lead times mean supply cannot be rapidly increased beyond existing stockpiles.Community engagement remains crucial. Past outbreaks have been prolonged by rumors, mistrust of health authorities, and resistance to infection control measures. In 2018-2020, misinformation spread on social media and by local political figures led to attacks on treatment centers and rejection of vaccination campaigns. said , a virologist at 's National Institute for Biomedical Research. The Congolese government has activated its national epidemic response committee and deployed military support to assist health workers accessing remote villages. Neighboring countries, particularly , have increased border surveillance and are screening travelers for symptoms.